These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22512247)

  • 21. Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis.
    Nijaguna MB; Patil V; Urbach S; Shwetha SD; Sravani K; Hegde AS; Chandramouli BA; Arivazhagan A; Marin P; Santosh V; Somasundaram K
    J Biol Chem; 2015 Sep; 290(38):23401-15. PubMed ID: 26245897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.
    Simmons ML; Lamborn KR; Takahashi M; Chen P; Israel MA; Berger MS; Godfrey T; Nigro J; Prados M; Chang S; Barker FG; Aldape K
    Cancer Res; 2001 Feb; 61(3):1122-8. PubMed ID: 11221842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution.
    Kim H; Zheng S; Amini SS; Virk SM; Mikkelsen T; Brat DJ; Grimsby J; Sougnez C; Muller F; Hu J; Sloan AE; Cohen ML; Van Meir EG; Scarpace L; Laird PW; Weinstein JN; Lander ES; Gabriel S; Getz G; Meyerson M; Chin L; Barnholtz-Sloan JS; Verhaak RG
    Genome Res; 2015 Mar; 25(3):316-27. PubMed ID: 25650244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting strategies on miRNA-21 and PDCD4 for glioblastoma.
    Wang G; Wang JJ; Tang HM; To SS
    Arch Biochem Biophys; 2015 Aug; 580():64-74. PubMed ID: 26142886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ.
    Escoll M; Gargini R; Cuadrado A; Anton IM; Wandosell F
    Oncogene; 2017 Jun; 36(25):3515-3527. PubMed ID: 28166194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 mutations versus EGF receptor expression in giant cell glioblastomas.
    Peraud A; Watanabe K; Plate KH; Yonekawa Y; Kleihues P; Ohgaki H
    J Neuropathol Exp Neurol; 1997 Nov; 56(11):1236-41. PubMed ID: 9370234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans.
    Feng H; Hu B; Liu KW; Li Y; Lu X; Cheng T; Yiin JJ; Lu S; Keezer S; Fenton T; Furnari FB; Hamilton RL; Vuori K; Sarkaria JN; Nagane M; Nishikawa R; Cavenee WK; Cheng SY
    J Clin Invest; 2011 Dec; 121(12):4670-84. PubMed ID: 22080864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of apoptosis in glioblastoma cells by inhibition of protein kinase C and its association with the rapid accumulation of p53 and induction of the insulin-like growth factor-1-binding protein-3.
    Shen L; Glazer RI
    Biochem Pharmacol; 1998 May; 55(10):1711-9. PubMed ID: 9634008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness.
    Cobbs CS; Soroceanu L; Denham S; Zhang W; Britt WJ; Pieper R; Kraus MH
    J Neurooncol; 2007 Dec; 85(3):271-80. PubMed ID: 17589804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The phosphoinositide 3-kinase signaling pathway as a therapeutic target in grade IV brain tumors.
    Höland K; Salm F; Arcaro A
    Curr Cancer Drug Targets; 2011 Oct; 11(8):894-918. PubMed ID: 21861842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Rb and mTOR signaling associates with synergistic anticancer effect of palbociclib and erlotinib in glioblastoma cells.
    Liu S; Tang Y; Yuan X; Yuan D; Liu J; Li B; Li Y
    Invest New Drugs; 2018 Dec; 36(6):961-969. PubMed ID: 29508248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma.
    Murat A; Migliavacca E; Gorlia T; Lambiv WL; Shay T; Hamou MF; de Tribolet N; Regli L; Wick W; Kouwenhoven MC; Hainfellner JA; Heppner FL; Dietrich PY; Zimmer Y; Cairncross JG; Janzer RC; Domany E; Delorenzi M; Stupp R; Hegi ME
    J Clin Oncol; 2008 Jun; 26(18):3015-24. PubMed ID: 18565887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RYK promotes the stemness of glioblastoma cells via the WNT/ β-catenin pathway.
    Adamo A; Fiore D; De Martino F; Roscigno G; Affinito A; Donnarumma E; Puoti I; Ricci Vitiani L; Pallini R; Quintavalle C; Condorelli G
    Oncotarget; 2017 Feb; 8(8):13476-13487. PubMed ID: 28086236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
    Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
    Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: a study of 54 patients.
    Ganigi PM; Santosh V; Anandh B; Chandramouli BA; Sastry Kolluri VR
    Pediatr Neurosurg; 2005; 41(6):292-9. PubMed ID: 16293948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted nitric oxide delivery preferentially induces glioma cell chemosensitivity via altered p53 and O(6) -methylguanine-DNA methyltransferase activity.
    Safdar S; Payne CA; Tu NH; Taite LJ
    Biotechnol Bioeng; 2013 Apr; 110(4):1211-20. PubMed ID: 23125026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on the expression of epidermal growth factor receptor and p53 in astrocytic gliomas: evidence for a distinct genetic pathway].
    Dong L; Pu PY; Wang H; Wang GX; Kang CS; Jiao DR
    Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):232-6. PubMed ID: 16776982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Automated network analysis identifies core pathways in glioblastoma.
    Cerami E; Demir E; Schultz N; Taylor BS; Sander C
    PLoS One; 2010 Feb; 5(2):e8918. PubMed ID: 20169195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical stratification of glioblastoma based on alterations in retinoblastoma tumor suppressor protein (RB1) and association with the proneural subtype.
    Goldhoff P; Clarke J; Smirnov I; Berger MS; Prados MD; James CD; Perry A; Phillips JJ
    J Neuropathol Exp Neurol; 2012 Jan; 71(1):83-9. PubMed ID: 22157621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glioblastoma and stem cells.
    Altaner C
    Neoplasma; 2008; 55(5):369-74. PubMed ID: 18665745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.